Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial.

导出 OA

翻译打印收藏纠错

作者： Melanie Schorr,Haines ^[1] ; Allison,Kimball ^[2] ; Erinne,Meenaghan ^[1] ; Katherine N,Bachmann ^[2] ; Kate,Santoso ^[1] ; Kamryn T,Eddy ^[1] ; Vibha,Singhal ^[2] ; Seda,Ebrahimi ^[1] ; Esther,Dechant ^[2] ; Thomas,Weigel ^[3] ; Lori,Ciotti ^[1] ; Robert J,Keane ^[2] ; Suzanne,Gleysteen ^[4] ; Diane,Mickley ^[2] ; Miriam A,Bredella ^[5] ; Can Ozan,Tan ^[2] ; Rajiv,Gupta ^[5] ; Madhusmita,Misra ^[6] ; David,Schoenfeld ^[7] ; Anne,Klibanski ^[2] ; Karen K,Miller ^[8]

作者单位： Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA. ^[1] Harvard Medical School, Boston, MA, USA. ^[2] Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, MA, USA. ^[3] Cambridge Eating Disorder Center, Cambridge, MA, USA. ^[4] Klarman Eating Disorders Center, Belmont, MA, USA. ^[5] The Renfrew Center, Boston, MA, USA. ^[6] Walden Behavioral Care, Waltham, MA, USA. ^[7] Beth Israel Deaconess Medical Center, Boston, MA, USA. ^[8] Wilkins Center for Eating Disorders, Greenwich, CT, USA. ^[9] Department of Radiology, Massachusetts General Hospital, Boston, MA, USA. ^[10] Spaulding Rehabilitation Hospital, Boston, MA, USA. ^[11] Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA. ^[12]

关键词 ANABOLICS ANTIRESORPTIVES DXA NUTRITION